Coldstream Capital Management Inc Igm Biosciences, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 2,626 shares of IGMS stock, worth $3,387. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,626Holding current value
$3,387% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IGMS
# of Institutions
79Shares Held
15.8MCall Options Held
39.1KPut Options Held
6K-
Baker Bros. Advisors LP New York, NY4.09MShares$5.28 Million0.28% of portfolio
-
Siren, L.L.C. New York, NY3.26MShares$4.2 Million0.21% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$3.81 Million1.41% of portfolio
-
Black Rock Inc. New York, NY883KShares$1.14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA876KShares$1.13 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $37.4M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...